Adma Biologics (ADMA) Interest Expenses (2011 - 2025)

Adma Biologics' Interest Expenses history runs 15 years deep, the most recent figure standing at $7.2 million for Q4 2025.

• Quarterly Interest Expenses rose 1974.15% year-over-year to $7.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.1 million (up 31.96% YoY) and the FY2025 annual result came in at $39.4 million, down 42.18% from the prior year.
• Interest Expenses was $7.2 million for Q4 2025 at Adma Biologics, up from $4.7 million in the prior quarter.
• Across five years, Interest Expenses topped out at $15.4 million in Q2 2025 and bottomed at -$16.4 million in Q4 2023.
• A 5-year average of $4.6 million and a median of $4.6 million in 2022 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2023 — Interest Expenses plunged 230.46% — and 2025, when it surged 1974.15%.
• Adma Biologics' Interest Expenses stood at $12.0 million in 2021, then rose by 5.21% to $12.6 million in 2022, then plunged by 230.46% to -$16.4 million in 2023, then soared by 97.67% to -$383000.0 in 2024, then jumped by 1974.15% to $7.2 million in 2025.
• Business Quant data shows ADMA's Interest Expenses at $7.2 million in Q4 2025, $4.7 million in Q3 2025, and $15.4 million in Q2 2025.